Facebook
Twitter
Telegram
Report an ErrorX4 Pharmaceuticals Cash Flow 2011-2024 | XFOR
Annual Cash Flow X4 Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-96.5 M | -77.1 M | -70.9 M | -58.8 M | -48.1 M | -25.4 M | -21.3 M | -21.6 M | - | - | - | - | - |
Depreciation & Amortization |
419 K | 513 K | 499 K | 351 K | 103 K | 103 K | 71 K | 285 K | - | - | - | - | - |
Accounts Payables |
8.95 M | 7.78 M | 4.28 M | 3.14 M | 2.09 M | 545 K | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow X4 Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-33.6 M | - | -68.8 M | -47.9 M | -26.5 M | - | -58 M | - | -20.2 M | - | -51.9 M | - | -18.4 M | - | -41.3 M | -27 M | -15.5 M | - | -38.8 M | -26 M | -11.8 M | - | -18.7 M | -12 M | -6.18 M | - | -15 M | -9.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
62 K | - | - | - | 127 K | - | 389 K | - | 133 K | - | 367 K | - | 106 K | - | 248 K | 102 K | 36 K | - | 71 K | 44 K | 20 K | - | 77 K | 51 K | 26 K | - | 148 K | 96 K | 48 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
8.94 M | 8.95 M | 8.13 M | 5.11 M | 5.99 M | 7.78 M | 3.8 M | - | 3.57 M | 4.28 M | 2.42 M | 2.53 M | 3.09 M | 3.14 M | 3.14 M | 3.14 M | 3.14 M | 2.09 M | 2.09 M | 2.09 M | 2.09 M | 2.97 M | 2.97 M | 2.97 M | 2.97 M | 1.89 M | 1.89 M | 1.89 M | 1.89 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency